19 hrs ago
U.S. Food and Drug Administration Approves Gilead's Zydelig ...
Zydelig is indicated in combination with rituximab for patients with relapsed chronic lymphocytic leukemia for whom rituximab alone would be considered appropriate therapy and as monotherapy for patients with relapsed follicular B-cell non-Hodgkin lymphoma and small lymphocytic lymphoma who have received at least two prior systemic therapies.
Tue Jul 29, 2014
2 doctors bonded by cancer now give back at Children's Hospital
Dr. Jeffrey Taub understands there is life after cancer. He spent his teenage years at the Children's Hospital Michigan winning his own fight against the disease.
Charley Honey: Cancer, chemo all part of spiritual journey for Sister Sue Tracy
Sister Sue Tracy chats with registered nurse Carol Yost, while her guardian-angel doll Ama looks on.
Medical News Today
SapC-DOPS selectively targets tumor cells in models with brain...
Over half of patients being seen in the clinic for a diagnosed brain tumor have metastatic cancer , which has no treatment and detrimental outcomes in most cases.
The Jersey Journal
CarePoint Health has announced that hematology and oncology specialist, Dr. Hitendra Upadhyaya, and physician Dr. Edward Boylan have joined the network, CarePoint Health Medical Group.
Mon Jul 28, 2014
FDA Expands Use of Imbruvica to Include CLL Patients with 17p Deletion
Well ahead of schedule, the US Food and Drug Administration today expanded the approved use of Imbruvica to treat patients with chronic lymphocytic leukemia who carry a deletion in chromosome 17 , associated with poor responses to standard treatment for CLL.
Sun Jul 27, 2014
Data: Shreveport specialist collected largest individual share of La. Medicare payments in '12
Hematolgist/oncologist Manish Dhawan's Medicare payments totaled slightly more than $5 million that year, according to data the U.S. Centers for Medicare and Medicaid released earlier this year.
Fri Jul 25, 2014
Blood thinner ineffective in preventing pregnancy complications from clots: study
Pregnant women with clotting disorders are often prescribed a challenging and cringe-inducing treatment - daily doses of a blood-thinner injected into the abdomen - in a bid to prevent a miscarriage or other complications.
Medical News Today
Biosimilar Retacrit effective in chemotherapy-induced anemia
Hospira, the world's leading provider of injectable drugs and infusion technologies, announced today that the results from the ORHEO study have been published in BMC Cancer , and show that the company's European biosimilar epoetin, Retacrit was effective and well tolerated in the management of chemotherapy-induced anemia in patients with solid ... (more)
Thu Jul 24, 2014
Heparin Does Not Reduce Pregnancy Complications, and May Create Some
For the past 20 years pregnant women with an increased risk of developing blood clots have often been prescribed a common blood thinner to prevent serious complications from the clots, including preeclampsia , disruption of the placenta, low birth weight and loss of the fetus.
Connecticut Children's Medical Center Welcomes Four New Physicians
Connecticut Children's Medical Center is pleased to announce the recent appointment of four new physicians to its Divisions of Hematology and Oncology, Emergency Medicine, Sleep Medicine and General Pediatrics.
Metastatic brain tumor treatment could be on the horizon with use of SapC-DOPS
Over half of patients being seen in the clinic for a diagnosed brain tumor have metastatic cancer, which has no treatment and detrimental outcomes in most cases.
Wed Jul 23, 2014
Study Results from Department of Hematology Update Understanding of...
Cytogenetically, 16 patients were defined as good risk, 56 as intermediate risk, and nine as poor risk, following the , "The pre-transplant conditioning regimen consisted of high-dose busulfan, etoposide, and cytarabine , combined with priming by granulocyte colony-stimulating factor .
FDA Approves Zydelig (idelalisib) for CLL and Lymphoma
July 23, 2014 -- The U.S. Food and Drug Administration today approved Zydelig to treat patients with three types of blood cancers.
Children's Hospital of San Antonio adding pediatric cancer expertise
The Children's Hospital of San Antonio has taken another step in its quest to develop a world-class pediatric cancer program.
Tue Jul 22, 2014
ASH honors Scott Armstrong, M.D., Ph.D., with 2014 William Dameshek Prize
The American Society of Hematology will present the 2014 William Dameshek Prize to Scott Armstrong, MD, PhD, of Memorial Sloan Kettering Cancer Center for his exceptional work in leukemia research and cancer stem cell biology.
Tomas Ganz, M.D., Ph.D., to present 2014 Ash E. Donnall Thomas Lecture
The American Society of Hematology will honor Tomas Ganz, MD, PhD, of the University of California - Los Angeles with the 2014 E. Donnall Thomas Lecture for his groundbreaking research in iron homeostasis, including the discovery of the iron-regulatory hormone hepcidin and investigation of its roles in iron metabolism.
WAFB-TV Baton Rouge
Scientists discover new way to make human platelets
Scientists report they have discovered a new way to make fully functional human platelets, which are the blood cells that form clots.